The high-level integration of technology in health care has radically changed the process of patient care, diagnosis, treatment, and health outcomes. This paper discusses significant technological advances: AI for medical imaging to detect early disease stages; robotic surgery with precision and minimally invasive techniques; telemedicine for remote monitoring and virtual consultation; personalized medicine through genomic analysis; and blockchain in secure and transparent handling of health data. Every section in the paper discusses the underlying principles, advantages, and disadvantages associated with such technologies, supported by appropriate case studies like deploying AI in radiology to enhance cancer diagnosis or robotic surgery to enhance accuracy in surgery and blockchain technology in electronic health records to enable data integrity and security. The paper also discusses key ethical issues, including risks to data privacy, algorithmic bias in AI-based diagnosis, patient consent problems in genomic medicine, and regulatory issues blocking the large-scale adoption of digital health solutions. The article also includes some recommended avenues of future research in the spaces where interdisciplinary cooperation, effective cybersecurity frameworks, and policy transformations are urgently required to ensure that new healthcare technology adoption is ethical and responsible. The work is aimed at delivering important information for policymakers and researchers who are interested in the changing roles of technology to improve healthcare provision and patient outcomes, as well as healthcare practitioners.

Thyroid cancer is one of the most common endocrine malignancies. Its incidence has steadily increased in recent years. Distinguishing between benign and malignant thyroid nodules (TNs) is challenging due to their overlapping imaging features. The rapid advancement of artificial intelligence (AI) in medical image analysis, particularly deep learning (DL) algorithms, has provided novel solutions for automated TN detection. However, existing studies exhibit substantial heterogeneity in diagnostic performance. Furthermore, no systematic evidence-based research comprehensively assesses the diagnostic performance of DL models in this field. This study aimed to execute a systematic review and meta-analysis to appraise the performance of DL algorithms in diagnosing TN malignancy, identify key factors influencing their diagnostic efficacy, and compare their accuracy with that of clinicians in image-based diagnosis. We systematically searched multiple databases, including PubMed, Cochrane, Embase, Web of Science, and IEEE, and identified 41 eligible studies for systematic review and meta-analysis. Based on the task type, studies were categorized into segmentation (n=14) and detection (n=27) tasks. The pooled sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC) were calculated for each group. Subgroup analyses were performed to examine the impact of transfer learning and compare model performance against clinicians. For segmentation tasks, the pooled sensitivity, specificity, and AUC were 82% (95% CI 79%-84%), 95% (95% CI 92%-96%), and 0.91 (95% CI 0.89-0.94), respectively. For detection tasks, the pooled sensitivity, specificity, and AUC were 91% (95% CI 89%-93%), 89% (95% CI 86%-91%), and 0.96 (95% CI 0.93-0.97), respectively. Some studies demonstrated that DL models could achieve diagnostic performance comparable with, or even exceeding, that of clinicians in certain scenarios. The application of transfer learning contributed to improved model performance. DL algorithms exhibit promising diagnostic accuracy in TN imaging, highlighting their potential as auxiliary diagnostic tools. However, current studies are limited by suboptimal methodological design, inconsistent image quality across datasets, and insufficient external validation, which may introduce bias. Future research should enhance methodological standardization, improve model interpretability, and promote transparent reporting to facilitate the sustainable clinical translation of DL-based solutions.

<i>"Just Accepted" papers have undergone full peer review and have been accepted for publication in <i>Radiology: Artificial Intelligence</i>. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content</i>. The MammosighTR dataset, derived from Türkiye's national breast cancer screening mammography program, provides BI-RADS-labeled mammograms with detailed annotations on breast composition and lesion quadrant location, which may be useful for developing and testing AI models in breast cancer detection. ©RSNA, 2025.

Hand and foot digital radiography (DR) is an indispensable tool in medical imaging, with varying diagnostic requirements necessitating different hand and foot positionings. Accurate positioning is crucial for obtaining diagnostically valuable images. Furthermore, adjusting exposure parameters such as exposure area based on patient conditions helps minimize the likelihood of image retakes. We propose a personalized positioning and exposure assistant capable of automatically recognizing hand and foot positionings and recommending appropriate exposure parameters to achieve these objectives. The assistant comprises three modules: (1) Progressive Iterative Hand-Foot Tracker (PIHFT) to iteratively locate hands or feet in RGB images, providing the foundation for accurate pose estimation; (2) Multi-Task Shared Pose Estimation Transformer (MTSPET), a Transformer-based model that encompasses hand and foot estimation branches with similar network architectures, sharing a common backbone. MTSPET outperformed MediaPipe in the hand pose estimation task and successfully transferred this capability to the foot pose estimation task; (3) Domain Expertise-embedded Positioning and Exposure Assistant (DEPEA), which combines the key-point coordinates of hands and feet with specific positioning and exposure parameter requirements, capable of checking patient positioning and inferring exposure areas and Regions of Interest (ROIs) of Digital Automatic Exposure Control (DAEC). Additionally, two datasets were collected and used to train MTSPET. A preliminary clinical trial showed strong agreement between PPEA's outputs and manual annotations, indicating the system's effectiveness in typical clinical scenarios. The contributions of this study lay the foundation for personalized, patient-specific imaging strategies, ultimately enhancing diagnostic outcomes and minimizing the risk of errors in clinical settings.

The rapid growth of multimodal medical imaging data presents significant storage and transmission challenges, particularly in resource-constrained clinical settings. We propose NEURAL, a novel framework that addresses this by using semantics-guided data compression. Our approach repurposes cross-attention scores between the image and its radiological report from a fine-tuned generative vision-language model to structurally prune chest X-rays, preserving only diagnostically critical regions. This process transforms the image into a highly compressed, graph representation. This unified graph-based representation fuses the pruned visual graph with a knowledge graph derived from the clinical report, creating a universal data structure that simplifies downstream modeling. Validated on the MIMIC-CXR and CheXpert Plus dataset for pneumonia detection, NEURAL achieves a 93.4-97.7\% reduction in image data size while maintaining a high diagnostic performance of 0.88-0.95 AUC, outperforming other baseline models that use uncompressed data. By creating a persistent, task-agnostic data asset, NEURAL resolves the trade-off between data size and clinical utility, enabling efficient workflows and teleradiology without sacrificing performance. Our NEURAL code is available at https://github.com/basiralab/NEURAL.

Arterial input function (AIF) extraction is a crucial step in quantitative pharmacokinetic modeling of DCE-MRI. This work proposes a robust deep learning model that can precisely extract an AIF from DCE-MRI images. A diverse dataset of human brain DCE-MRI images from 289 participants, totaling 384 scans, from five different institutions with extracted gadolinium-based contrast agent curves from large penetrating arteries, and with most data collected for blood-brain barrier (BBB) permeability measurement, was retrospectively analyzed. A 3D UNet model was implemented and trained on manually drawn AIF regions. The testing cohort was compared using proposed AIF quality metric AIFitness and K^trans values from a standard DCE pipeline. This UNet was then applied to a separate dataset of 326 participants with a total of 421 DCE-MRI images with analyzed AIF quality and K^trans values. The resulting 3D UNet model achieved an average AIFitness score of 93.9 compared to 99.7 for manually selected AIFs, and white matter K^trans values were 0.45/min × 10^-3 and 0.45/min × 10^-3, respectively. The intraclass correlation between automated and manual K^trans values was 0.89. The separate replication dataset yielded an AIFitness score of 97.0 and white matter K^trans of 0.44/min × 10^-3. Findings suggest a 3D UNet model with additional convolutional neural network kernels and a modified Huber loss function achieves superior performance for identifying AIF curves from DCE-MRI in a diverse multi-center cohort. AIFitness scores and DCE-MRI-derived metrics, such as K^trans maps, showed no significant differences in gray and white matter between manually drawn and automated AIFs.

Total-body dual X-ray absorptiometry (TBDXA) imaging is a relatively low-cost whole-body imaging modality, widely used for body composition assessment. We develop and validate a deep learning method for automatic fiducial point placement on TBDXA scans using 1,683 manually-annotated TBDXA scans. The method achieves 99.5% percentage correct keypoints in an external testing dataset. To demonstrate the value for shape and appearance modeling (SAM), our method is used to place keypoints on 35,928 scans for five different TBDXA imaging modes, then associations with health markers are tested in two cohorts not used for SAM model generation using two-sample Kolmogorov-Smirnov tests. SAM feature distributions associated with health biomarkers are shown to corroborate existing evidence and generate new hypotheses on body composition and shape's relationship to various frailty, metabolic, inflammation, and cardiometabolic health markers. Evaluation scripts, model weights, automatic point file generation code, and triangulation files are available at https://github.com/hawaii-ai/dxa-pointplacement.

Polycystic ovary syndrome (PCOS) has a significant impact on endocrine metabolism, reproductive function, and mental health in women of reproductive age. Ultrasound remains an essential diagnostic tool for PCOS, particularly in individuals presenting with oligomenorrhea or ovulatory dysfunction accompanied by polycystic ovaries, as well as hyperandrogenism associated with polycystic ovaries. However, the accuracy of ultrasound in identifying polycystic ovarian morphology remains variable. To develop a deep learning model capable of rapidly and accurately identifying PCOS using ovarian ultrasound images. Prospective diagnostic accuracy study. This prospective study included data from 1,751 women with suspected PCOS who presented at two affiliated hospitals at Central South University, with clinical and ultrasound information collected and archived. Patients from center 1 were randomly divided into a training set and an internal validation set in a 7:3 ratio, while patients from center 2 served as the external validation set. Using the YOLOv11 deep learning framework, an automated recognition model for ovarian ultrasound images in PCOS cases was constructed, and its diagnostic performance was evaluated. Ultrasound images from 933 patients (781 from center 1 and 152 from center 2) were analyzed. The mean average precision of the YOLOv11 model in detecting the target ovary was 95.7%, 97.6%, and 97.8% for the training, internal validation, and external validation sets, respectively. For diagnostic classification, the model achieved an F1 score of 95.0% in the training set and 96.9% in both validation sets. The area under the curve values were 0.953, 0.973, and 0.967 for the training, internal validation, and external validation sets respectively. The model also demonstrated significantly faster evaluation of a single ovary compared to clinicians (doctor, 5.0 seconds; model, 0.1 seconds; <i>p</i> < 0.01). The YOLOv11-based automatic recognition model for PCOS ovarian ultrasound images exhibits strong target detection and diagnostic performance. This approach can streamline the follicle counting process in conventional ultrasound and enhance the efficiency and generalizability of ultrasound-based PCOS assessment.

To evaluate the post-deployment performance of an artificial intelligence (AI) system (Aidoc) for intracranial hemorrhage (ICH) detection and assess the utility of ChatGPT-4 Turbo for automated AI monitoring. This retrospective study evaluated 332,809 head CT examinations from 37 radiology practices across the United States (December 2023-May 2024). Of these, 13,569 cases were flagged as positive for ICH by the Aidoc AI system. A HIPAA (Health Insurance Portability and Accountability Act) -compliant version of ChatGPT-4 Turbo was used to extract data from radiology reports. Ground truth was established through radiologists' review of 200 randomly selected cases. Performance metrics were calculated for ChatGPT, Aidoc and radiologists. ChatGPT-4 Turbo demonstrated high diagnostic accuracy in identifying intracranial hemorrhage (ICH) from radiology reports, with a positive predictive value of 1 and a negative predictive value of 0.988 (AUC:0.996). Aidoc's false positive classifications were influenced by scanner manufacturer, midline shift, mass effect, artifacts, and neurologic symptoms. Multivariate analysis identified Philips scanners (OR: 6.97, p=0.003) and artifacts (OR: 3.79, p=0.029) as significant contributors to false positives, while midline shift (OR: 0.08, p=0.021) and mass effect (OR: 0.18, p=0.021) were associated with a reduced false positive rate. Aidoc-assisted radiologists achieved a sensitivity of 0.936 and a specificity of 1. This study underscores the importance of continuous performance monitoring for AI systems in clinical practice. The integration of LLMs offers a scalable solution for evaluating AI performance, ensuring reliable deployment and enhancing diagnostic workflows.

Generative AI holds great potentials to automate and enhance data synthesis in nuclear medicine. However, the high-stakes nature of biomedical imaging necessitates robust mechanisms to detect and manage unexpected or erroneous model behavior. We introduce development and implementation of a hybrid anomaly detection framework to safeguard GenAI models in BIOEMTECH's eyes(TM) systems. Two applications are demonstrated: Pose2Xray, which generates synthetic X-rays from photographic mouse images, and DosimetrEYE, which estimates 3D radiation dose maps from 2D SPECT/CT scans. In both cases, our outlier detection (OD) enhances reliability, reduces manual oversight, and supports real-time quality control. This approach strengthens the industrial viability of GenAI in preclinical settings by increasing robustness, scalability, and regulatory compliance.